CELEX: 62021TN0543
Language: en
Date: 2021-09-02 00:00:00
Title: Case T-543/21: Action brought on 2 September 2021 — Purasac v EUIPO — Prollenium Medical Technologies (Rejeunesse)

18.10.2021   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 422/34
            
         
      Action brought on 2 September 2021 — Purasac v EUIPO — Prollenium Medical Technologies (Rejeunesse)
      (Case T-543/21)
      (2021/C 422/44)
      Language of the case: English
      
         Parties
      
      
         Applicant: Purasac Co. Ltd (Anyang-si, Republic of Korea) (represented by: P. Lee, lawyer)
      
         Defendant: European Union Intellectual Property Office (EUIPO)
      
         Other party to the proceedings before the Board of Appeal: Prollenium Medical Technologies, Inc. (Aurora, Ontario, Canada)
      
         Details of the proceedings before EUIPO
      
      
         Applicant of the trade mark at issue: Applicant before the General Court
      
         Trade mark at issue: Application for European Union figurative mark Rejeunesse — Application for registration No 18 117 313
      
         Procedure before EUIPO: Opposition proceedings
      
         Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 2 July 2021 in Case R 146/2021-4
      
         Form of order sought
      
      The applicant claims that the Court should:
      
                  —
               
               
                  annul the contested decision;
               
            
                  —
               
               
                  order EUIPO to pay the costs.
               
            
         Plea in law
      
      
                  —
               
               
                  Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council in the erroneous assessment of the likelihood of confusion between the trade marks.